Gardasil®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) helps protect girls and women ages 9 to 45 against cervical, vaginal, vulvar, and anal cancers and genital warts caused by 9 types of HPV.
Gardasil 9 helps protect boys and men ages 9 to 45 against anal cancer and genital warts caused by those same HPV types.
Gardasil 9 may not fully protect everyone, nor will it protect against diseases caused by other HPV types or against diseases not caused by HPV.
Gardasil 9 does not prevent all types of cervical cancer, so it’s important for women to continue routine cervical cancer screenings. Gardasil 9 does not treat cancer or genital warts.
Gardasil 9 is a shot that is usually given in the arm muscle. Gardasil 9 may be given as 2 or 3 shots.
For the 2-dose schedule, the second dose should be administered 6–12 months after the first dose.
If the second dose is administered less than 5 months after the first dose, a third dose should be given at least 4 months after the second dose.
For individuals 15 through 45 years of age, the 3-dose schedule should be followed and Gardasil 9 should be administered at 0, 2 months, and 6 months.